NCT06781983
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06781983
Title Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Innate Pharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Massachusetts General Hospital - Boston RECRUITING Boston Massachusetts 02114 United States Details
John Theurer Cancer Center RECRUITING Hackensack New Jersey 07601 United States Details
Mount Sinai Tisch Cancer Center RECRUITING New York New York 10029 United States Details
NEXT Oncology - Dallas RECRUITING Dallas Texas 75039 United States Details
NEXT Oncology - Virginia RECRUITING Fairfax Virginia 22031 United States Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Gustave Roussy Cancer Institute RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field